News
Minomic at Asia Global Health Summit 2026
Minomic is pleased to announce its participation in a deal-making session at the Asia Summit on Global Health, taking place on 11–12 May 2026 at the Hong Kong Convention and Exhibition Centre (HKCEC). This premier global forum brings together leading healthcare...
Minomic and Doc Lab at LUGPA 2026 Global Prostate Cancer Congress
We’re proud to partner with Doc Lab Inc. at the LUGPA 2026 Global Prostate Cancer Congress, where our teams will be exhibiting together in support of advancing prostate cancer diagnostics. 📅 January 10–13, 2026📍 Grand Hyatt Deer Valley | Park City,...
Minomic at JPM Healthcare Week 2026
Minomic will be in San Francisco during JPM Healthcare Week, connecting with partners and investors through curated forums and 1:1 meetings. We’ll be participating in the QNova LifeSciences JPM Partnering Forum and meeting privately throughout the week to discuss...
Minomic at LUGPA 2025
Minomic and Doc Lab Inc. are teaming up at LUGPA2025 in Chicago — and we can’t wait to connect with the urology community. We have an 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐞𝐯𝐞𝐧𝐭 𝐩𝐥𝐚𝐧𝐧𝐞𝐝 that you won’t want to miss! Be sure to stop by and learn more about how we’re advancing prostate cancer...
Join us for an Educational Dinner Event
We invite you to an evening of learning and networking as we introduce MiCheck® Prostate — a next-generation blood test designed to help clinicians better identify men at increased risk for clinically significant prostate cancer. 📍 Eddie Merlot’s, 505 Congress Street,...
Doc Lab Partnership Announcement
We're thrilled to announce our strategic partnership with Doc Lab Incorporated! Doc Lab has been named a Top 10 Lab Management Company by Med Health. The Game-Changer: Through our collaboration with Doc Lab, MiCheck® Prostate is now available right in your office —...
Exciting Milestone for Minomic: MiCheck® Prostate Receives PLA Code Assignment!
We are proud to announce that the American Medical Association (AMA) has accepted our PLA Code application for MiCheck® Prostate. This next-generation blood test helps urologists identify the risk of clinically significant prostate cancer. Effective October 1, 2025,...
Minomic at AUA 2025
Minomic Inc attended the 120th American Urological Association Annual Meeting in Las Vegas on 26-29 April — a key global gathering for urology leaders and innovators. CEO of Minomic Inc, Sushmita Utpala, had the opportunity to meet with two incredible leaders shaping...
Minomic Inc Ushers in a New Era of Growth in U.S. with Sushmita Utpala as CEO of Minomic Inc!
We are thrilled to announce a significant milestone in Minomic's journey: the appointment of Sushmita Utpala as our new Minomic Inc.’s Chief Executive Officer! After a period of dedicated preparation, we are eager to share this exciting news and the vision that...
Asia Summit on Global Health in Hong Kong
David Burdis is attending the Asia Summit on Global Health in Hong Kong as part of the Investment NSW delegation. During this event, he has been able to present the benefits of MiCheck® Prostate to numerous interested parties including Professor Chung-Mau Lo, HK...
New Peer-Reviewed Paper on MiCheck® Prostate
Minomic is pleased to announce the publication of the company’s latest research paper supporting the utilisation of MiCheck® Prostate as an aid to diagnosing clinically significant prostate cancer. It is clear there is strong clinical need to identify those patients...
Dr Brad Walsh’s interview on Australia’s leading business and finance streaming service AusBiz
Last Thursday Dr Brad Walsh was interviewed on Australia's leading business and finance streaming service, AusBiz by renowned TV personality David Koch about Minomic’s technology and future plans as a fitting end to Prostate Cancer Awareness Month. You can view it...
Minomic International Ltd Receives Reimbursement for MiCheck® Prostate in the USA
Thursday 28 September, Sydney, Australia Sydney-based biotech Minomic International Ltd is delighted to announce that the company’s ground-breaking test for prostate cancer, MiCheck® Prostate, has received its first reimbursement in the United States from the Centres...
Minomic’s presentation at the 23rd Asia-Pacific Prostate Cancer Conference
We are proud to be presenting at the 23rd Asia-Pacific Prostate Cancer Conference, one of the largest comprehensive prostate cancer meetings in the world, that is being held between 18 - 20 August 2023 in Cairns. Minomic CEO, Dr Brad Walsh will present a poster...
Minomic’s participation at the AUA 2023
The Minomic International Ltd team was delighted to share our new findings on the application of MiCheck® Prostate with MRI-derived data at the poster presentation session at the American Urological Association's 2023 Annual Meeting on April 28 2023 in Chicago. It was...
Minomic joins Macquarie University at the DeepTech Incubator
We are pleased to announce that Minomic International Ltd has officially joined Macquarie University at the DeepTech Incubator. “We are excited to continue our partnership with the Macquarie University Incubator, working with them to continue growing Minomic to its...
